If you’ve found yourself lying awake at 3am with a racing heart, snapping at people you love for no clear reason, or feeling a creeping sense of dread that seems to come from nowhere, and you’re somewhere in your forties, there’s a good chance your hormones are involved. If this feels unfamiliar and out of character, it is worth paying attention rather than dismissing it as stress alone. Perimenopause anxiety is one of the most common and least talked-about symptoms of the hormonal transition that precedes menopause, and for many women, it arrives long before the hot flushes do.
Understanding why it happens, and what can actually help, starts with two hormones: oestrogen and progesterone.
The Hormonal Shift That Changes Everything
Perimenopause typically begins in a woman’s mid to late forties, though it can start as early as 40. It is defined not by a single moment but by a gradual, often erratic decline in ovarian hormone production, and it is the fluctuation, rather than just the decline, that tends to drive the most distressing psychological symptoms. In early perimenopause, hormones are often not simply low, they are unpredictable and uneven.
Oestrogen (estrogen) is far more than a reproductive hormone. It plays a direct role in the regulation of serotonin, dopamine, and noradrenaline, three of the brain’s most important mood regulating neurotransmitters. When oestrogen levels are stable, these systems function with relative consistency. When oestrogen (estrogen) begins to fluctuate unpredictably, as it does in perimenopause, the brain’s chemical environment becomes unstable.
Research published in the journal Psychoneuroendocrinology has shown that oestrogen (estrogen) withdrawal activates the amygdala, the brain’s threat detection center, making it more reactive to stressors that would previously have passed without notice. In practical terms, this means the perimenopausal brain is neurologically primed for anxiety, not because something is wrong with you, but because of a measurable shift in brain chemistry.
Progesterone’s role is equally important, and arguably less well understood by most women. Progesterone is the body’s natural calming hormone. It binds to GABA receptors in the brain, the same receptors targeted by benzodiazepine medications like diazepam, producing a mild anxiolytic effect. Progesterone is converted into allopregnanolone, a neurosteroid with a powerful calming effect on the brain. A metabolite of progesterone called allopregnanolone is particularly potent in this regard, and researchers at Uppsala University have found that women with lower allopregnanolone levels are significantly more vulnerable to anxiety and mood disturbance. As progesterone declines during perimenopause, this natural calming effect is progressively withdrawn, often leaving women feeling wired, on edge, and unable to switch off.
The two processes compound each other. Falling progesterone removes the brain’s natural sedative buffer at the same time that fluctuating oestrogen is increasing amygdala reactivity. This is not a coincidence, it is a specific, documented neurobiological phenomenon that research in Frontiers in Neuroendocrinology has described as producing a vulnerability window for mood and anxiety disorders in midlife women.
What Perimenopause Anxiety Actually Feels Like
One of the reasons perimenopause anxieties so often goes unrecognized, both by women themselves and by clinicians, is that it does not always look like textbook anxiety. Many women describe it less as a constant worry and more as a new and unfamiliar internal agitation: a low-level hum of unease that makes ordinary situations feel disproportionately threatening. Unlike generalized anxiety, these symptoms may appear suddenly, without a clear trigger, and can fluctuate across the menstrual cycle.
Common presentations include heart palpitations that appear without obvious cause, sudden episodes of panic that feel physical rather than psychological, an inability to wind down in the evenings, waking in the early hours with a sense of impending doom, heightened irritability, and a feeling of being emotionally overwhelmed by tasks that would previously have felt manageable. A 2023 analysis published in the British Journal of General Practice found that women in the perimenopausal transition are two to four times more likely to experience new onset anxiety compared to their premenopausal baseline, with many cases going undiagnosed because both patient and healthcare provider attribute the symptoms to life stress rather than hormonal change.
It is also worth noting that perimenopause anxiety frequently accompanies disrupted sleep, which creates its own compounding cycle. Poor sleep elevates cortisol, the body’s primary stress hormone, and chronically elevated cortisol further suppresses progesterone production, meaning that sleeplessness driven by hormonal change actively worsens the hormonal imbalance causing it in the first place.
If you recognize these symptoms and you are between 40 and 55, it is worth raising perimenopause specifically with a doctor or healthcare provider rather than presenting with anxiety alone. The distinction matters, because the treatment pathways are different.
What Actually Helps: HRT (hormone replacement therapy), Supplements, and Lifestyle
The most effective and evidence-based treatment for perimenopause anxiety rooted in hormonal change is hormone replacement therapy. HRT works by stabilizing the oestrogen (estrogen)and progesterone fluctuations that are driving the neurological instability, rather than simply managing the downstream psychological symptoms. A Cochrane review examining HRT outcomes in perimenopausal women found that oestrogen therapy significantly reduced anxiety and mood disturbance compared to placebo, with effects that were most pronounced in women whose symptoms were directly linked to the hormonal transition rather than to preexisting mental health conditions. HRT is not suitable for everyone, and individual risks and benefits should always be assessed with a healthcare professional.
The type of HRT matters. Body identical progesterone (micronized progesterone), available under different brand names in various countries, is often considered preferable to older synthetic progestogens for women with anxiety and sleep difficulties. as it preserves more of the allopregnanolone mediated calming effect that synthetic versions lack. If you are considering HRT, asking your doctor or healthcare provider about body identical progesterone specifically is worth doing.
For women who are not yet ready for HRT, or who are managing milder symptoms, certain supplements have a reasonable evidence base. These may offer supportive benefit but do not replace hormone-based treatment where clinically indicated.
• Magnesium glycinate, taken at a dose of 200 to 400mg before bed, has been shown in a review published in Nutrients to reduce anxiety and improve sleep quality through its action on GABA receptors, a mechanism that partially mirrors progesterone’s calming effect.
• Ashwagandha (Withania somnifera) has been studied for its cortisol lowering properties, with a randomized controlled trial published in Medicine finding significant reductions in perceived stress and anxiety scores in adults taking 300mg twice daily compared to placebo. It is worth noting that ashwagandha should be used with caution in women with thyroid conditions, and a pharmacist consultation is advisable before starting it. Supplement quality can vary significantly, so choosing reputable, tested brands is important.
• Vitamin B6 is another nutrient frequently cited in the context of hormonal mood regulation. It is involved in serotonin synthesis and has historically been used for premenstrual mood symptoms; some clinicians extend this rationale to perimenopause, though the evidence base is less robust than for HRT or magnesium specifically.
• On the lifestyle side, the evidence consistently points to three interventions, resistance exercise, sleep hygiene, and reduction of blood sugar volatility. Resistance training has been shown in a study in the journal Menopause to reduce anxiety and depressive symptoms in perimenopausal women independently of weight change, likely through its effects on BDNF, a brain derived protein that supports neurological resilience. Blood sugar management is particularly relevant because glucose spikes and crashes activate the same stress response pathways as anxiety, and a diet high in refined carbohydrates can functionally worsen hormonal anxiety even in women who do not have diabetes or insulin resistance.
What tends to help most, in order of evidence, is stabilizing hormones where appropriate, supporting sleep quality, reducing physiological stress load, and building neurological resilience over time.
When to See a doctor or Healthcare Provider
Perimenopause anxiety is a medical symptom, not a character flaw or a sign that you cannot cope. If your anxiety is new, has emerged or significantly worsened in your forties, and is accompanied by other perimenopausal signs, irregular periods, disrupted sleep, palpitations, changes in temperature regulation, it deserves proper clinical evaluation. Asking a doctor or healthcare provider directly about the perimenopausal transition, and whether HRT might be appropriate, is a reasonable and evidence-supported step.
International clinical guidelines on menopause management, including recommendations from major menopause and endocrine societies, support the use of hormone replacement therapy (HRT) for psychological symptoms during the menopause transition when these affect quality of life. This means anxiety associated with hormonal changes is a valid and evidence supported reason to explore treatment options with a healthcare professional.
You do not have to wait until you have hot flushes to be taken seriously.
FAQs
Q1. Can perimenopause cause anxiety even if my periods are still regular?
Yes, Hormonal fluctuations, particularly in progesterone, can begin several years before periods become irregular. Many women experience mood and anxiety changes as one of the earliest signs of the perimenopausal transition, while their cycle appears outwardly normal.
Q2. Is perimenopause anxiety the same as an anxiety disorder?
Not exactly, Perimenopause anxiety has a specific hormonal mechanism and typically responds to hormone-targeted treatment. That said, it can trigger or worsen an existing anxiety disorder, and the two can coexist. A thorough clinical assessment is important to distinguish between them.
Q3. Will HRT make my anxiety worse?
For most women with perimenopause related anxiety, HRT improves rather than worsens symptoms by stabilizing the hormonal fluctuations driving them. However, the type of progestogen used matters, synthetic progestogens can worsen mood in some women, which is one reason body-identical progesterone is increasingly preferred.
Q4. How long does perimenopause anxiety last?
This varies considerably. The perimenopausal transition typically lasts between four and eight years. For many women, anxiety symptoms improve once hormone levels stabilize in postmenopause, though this is not universal. Treatment during the transition can significantly reduce the duration and severity of symptoms.
Q5. Can I take antidepressants instead of HRT?
SSRIs and SNRIs can be effective for anxiety and are sometimes appropriate, particularly where there is a co-existing mood disorder. However, they do not address the underlying hormonal cause of perimenopausal anxiety and are not recommended as first line treatment by international menopause guidance (including NICE NG23) for women whose symptoms are primarily driven by the menopause transition.
Call to Action
Feeling anxious in your forties and not sure why? Your hormones may be playing a role. If this feels familiar, don’t dismiss it as “just stress.” Speaking with a doctor or healthcare provider can be an important first step. You can also speak to a pharmacist if you want to better understand your symptoms and possible next steps before seeking treatment.
Disclaimer
This article is for informational purposes only and does not constitute medical advice. If you are experiencing symptoms that are affecting your daily life, please consult a doctor or qualified healthcare professional. HRT and supplements should only be started following appropriate clinical assessment.
References
• Psychoneuroendocrinology, oestrogen withdrawal and amygdala reactivity in perimenopausal women
• Frontiers in Neuroendocrinology, vulnerability window for mood and anxiety disorders during the perimenopausal transition
• Uppsala University research, allopregnanolone levels and anxiety susceptibility in women with progesterone decline
• British Journal of General Practice (2023), perimenopausal women two to four times more likely to experience new-onset anxiety compared to premenopausal baseline
• Cochrane Review, HRT and reduction of anxiety and mood disturbance in perimenopausal women versus placebo
• Nutrients, magnesium glycinate, GABA receptor activity, anxiety reduction and sleep quality
• Medicine (randomized controlled trial), ashwagandha 300mg twice daily and significant reductions in perceived stress and anxiety versus placebo
• Menopause journal, resistance training and reduction of anxiety and depressive symptoms in perimenopausal women independent of weight change
• NICE Guideline NG23. HRT recommended for psychological symptoms associated with the menopause transition impacting quality of life
